Literature DB >> 19617752

Outcomes for patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis.

Lei Lian1, Victor W Fazio, Feza H Remzi, Bo Shen, David Dietz, Ravi P Kiran.   

Abstract

PURPOSE: Continent ileostomy is considered an alternative for patients with a failed ileal pouch-anal anastomosis. The aim of this study is to investigate outcomes for patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis at our institution.
METHODS: Patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis were identified from a prospectively maintained pouch database. Quality-of-life scores were obtained by telephone follow-up or office visit and were determined by the Cleveland Global Quality of Life Score.
RESULTS: Sixty-four patients were identified between 1982 and 2007. Forty-two percent were male. The median age was 36.5 (range, 14-61) years. Most common diagnoses included ulcerative colitis (n = 44, 68.8%) and Crohn's disease (n = 13, 20.3%). The indication for continent ileostomy was septic pouch complications in 56.3% patients. The previous pelvic pouch was used in 16 (25%) patients. The 30-day complication rate was 31.3%. There were no perioperative deaths. Median follow-up was five years. The long-term dysfunction rate was 50%, the complication rate was 60.9%, and the revision rate 45.3%. The median revision-free interval was 2.8 years (range, 3 months to 19 years) and the retention rate of continent ileostomy was 95.3% (61 of 64). Median continent ileostomy survival time was 4.2 (range, 1-19) years. The median quality-of-life score was 0.77.
CONCLUSIONS: Continent ileostomy is possible in patients wishing to avoid an external appliance after pelvic pouch failure. Despite the associated morbidity, most of this select group of highly motivated patients retain their continent ileostomy long-term and are highly satisfied with their choice of continent ileostomy.

Entities:  

Mesh:

Year:  2009        PMID: 19617752     DOI: 10.1007/DCR.0b013e3181ab586b

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

1.  A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.

Authors:  F Selvaggi; G Pellino; G Ghezzi; D Corona; G Riegler; G G Delaini
Journal:  Tech Coloproctol       Date:  2015-09-19       Impact factor: 3.781

Review 2.  Health related quality of life in inflammatory bowel disease: the impact of surgical therapy.

Authors:  Konstantin Umanskiy; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

Review 3.  The Failed J Pouch.

Authors:  Emmanouil P Pappou; Ravi P Kiran
Journal:  Clin Colon Rectal Surg       Date:  2016-06

4.  Ultimate fate of the leaking intestinal anastomosis: does leak mean permanent stoma?

Authors:  Todd D Francone; Abdulaziz Saleem; Thomas A Read; Patricia L Roberts; Peter W Marcello; David J Schoetz; Rocco Ricciardi
Journal:  J Gastrointest Surg       Date:  2010-04-07       Impact factor: 3.452

Review 5.  Diagnosis and differential diagnosis of Crohn's disease of the ileal pouch.

Authors:  Yue Li; Bin Wu; Bo Shen
Journal:  Curr Gastroenterol Rep       Date:  2012-10

Review 6.  Endoscopic evaluation of surgically altered bowel in patients with inflammatory bowel diseases.

Authors:  Preetika Sinh; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

Review 7.  Continent Ileostomy as an Alternative to End Ileostomy.

Authors:  Xian-Rui Wu; Hao-Xian Ke; Ravi P Kiran; Bo Shen; Ping Lan
Journal:  Gastroenterol Res Pract       Date:  2020-01-10       Impact factor: 2.260

8.  Salvage surgery for continent ileostomies (CI) after a first successful revision: more long-term blame on the reservoir than the nipple valve.

Authors:  Karl-Wilhelm Ecker; Mathias Tönsmann; Nils Karl Josef Ecker; Gabriela Möslein
Journal:  Int J Colorectal Dis       Date:  2021-10-30       Impact factor: 2.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.